語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Topical delivery of a novel antisens...
~
Asbill, Charles Scott.
FindBook
Google Book
Amazon
博客來
Topical delivery of a novel antisense oligonucleotide and validation of a bioengineered skin model.
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Topical delivery of a novel antisense oligonucleotide and validation of a bioengineered skin model./
作者:
Asbill, Charles Scott.
面頁冊數:
187 p.
附註:
Major Professor: Bozena B. Michniak.
Contained By:
Dissertation Abstracts International62-02B.
標題:
Health Sciences, Pharmacy. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3006004
ISBN:
0493148973
Topical delivery of a novel antisense oligonucleotide and validation of a bioengineered skin model.
Asbill, Charles Scott.
Topical delivery of a novel antisense oligonucleotide and validation of a bioengineered skin model.
- 187 p.
Major Professor: Bozena B. Michniak.
Thesis (Ph.D.)--University of South Carolina, 2000.
During the last decade, research in the area of transdermal and topical drug delivery has expanded greatly. This interest can be attributed to the many advantages offered by this route of administration. Such advantages include but are not limited to: (1) avoidance of the first pass effect; (2) controlled drug release; (3) non-invasive drug delivery and, (4) improved patient compliance.
ISBN: 0493148973Subjects--Topical Terms:
1017737
Health Sciences, Pharmacy.
Topical delivery of a novel antisense oligonucleotide and validation of a bioengineered skin model.
LDR
:03235nam 2200301 a 45
001
932968
005
20110505
008
110505s2000 eng d
020
$a
0493148973
035
$a
(UnM)AAI3006004
035
$a
AAI3006004
040
$a
UnM
$c
UnM
100
1
$a
Asbill, Charles Scott.
$3
1256709
245
1 0
$a
Topical delivery of a novel antisense oligonucleotide and validation of a bioengineered skin model.
300
$a
187 p.
500
$a
Major Professor: Bozena B. Michniak.
500
$a
Source: Dissertation Abstracts International, Volume: 62-02, Section: B, page: 0802.
502
$a
Thesis (Ph.D.)--University of South Carolina, 2000.
520
$a
During the last decade, research in the area of transdermal and topical drug delivery has expanded greatly. This interest can be attributed to the many advantages offered by this route of administration. Such advantages include but are not limited to: (1) avoidance of the first pass effect; (2) controlled drug release; (3) non-invasive drug delivery and, (4) improved patient compliance.
520
$a
Unfortunately, not all drugs can be delivered transdermally due to the complex nature of the skin. It is composed of two primary layers, the epidermis and the underlying dermis. The dermis contains mainly collagen and other matrix proteins, and functions primarily to provide insulation and mechanical support for the overlying epidermal layer. Five primary cell layers make up the epidermis. Its uppermost layer is the stratum corneum. The stratum corneum is the rate limiting step in the diffusion of chemical agents across the skin. The stratum corneum is composed of protein filled cells called corneocytes that are embedded in a lipid matrix. Primary objectives of the research described in this dissertation were to deliver a antisense olignucleotide therapeutic agent across the skin and to examine the ability of a human skin equivalent to serve as an <italic> in vitro</italic> model for transdermal testing.
520
$a
The project involving the topical delivery of the antisense oligonucleotide was essentially a drug development project. We evaluated the ability of known permeation enhancers and GRAS (generally regarded as safe) compounds to enhance the delivery of this large molecular weight macromolecule into the skin layers. There was a large initial screeing mode in which the best enhancers were selected for formulation into a cream. Following this there was massive permeability testing, physical stability testing, and biological testing of the products. Currently, the antisense oligonucleotide and cream formulation are being evaluated in clinical trials.
520
$a
In order to evaluate the physiology of the skin, skin alternatives have been under development for several years. In this project we set out to develop and screen a skin alternative with properties similar to that of human cadaver skin. In terms of permeability, lipid composition, and histology, human skin has been simulated.
590
$a
School code: 0202.
650
4
$a
Health Sciences, Pharmacy.
$3
1017737
690
$a
0572
710
2 0
$a
University of South Carolina.
$3
1017477
773
0
$t
Dissertation Abstracts International
$g
62-02B.
790
$a
0202
790
1 0
$a
Michniak, Bozena B.,
$e
advisor
791
$a
Ph.D.
792
$a
2000
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3006004
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9103656
電子資源
11.線上閱覽_V
電子書
EB W9103656
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入